ClinicalTrials.gg
Active, not recruitingNCT07930351Updated Nov 12, 2026

Aerobic Exercise Added to Diaphragmatic Breathing for Nocturnal Enuresis in Overweight and Obese Children

An interventional study of Aerobic Exercise and Diaphragmatic Breathing in Nocturnal Enuresis, Pediatric Obesity and Overweight, sponsored by Hungarian University of Sports Science. Active, not recruiting at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Hungarian University of Sports Science · Not applicable, Interventional, and Treatment

Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 22 studies in Nocturnal Enuresis with a site in Egypt — 5 open to participants now, 7 under way, 2 of them phase 3. Nocturnal Enuresis · Egypt.

Enrollment
16th of 18
51 · median 95
Started
2026
with 1 other
No phase
13 of 22
4 open now
Registered
22nd of 22
by date
Lead sponsor
2 of 22
Hungarian University of Sports Science

Among the 22 studies in Nocturnal Enuresis with a site in Egypt, this one is the 16th largest by enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2026, is one of 13 with no phase, and was the 22nd registered.

Nocturnal Enuresis

105 studies on the registry are indexed under Nocturnal Enuresis; 22 are open to participants now.

Browse Nocturnal Enuresis studies →

Open to participants now

5 of the 22 studies in Nocturnal Enuresis with a site in Egypt are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 14 Nocturnal Enuresis studies recruiting now, 5 (36%) set no upper age limit and 9 (64%) stop at 75 or younger; 8 take children under 18; 2 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Nocturnal Enuresis with a site in Egypt, or all of them as a file.
02

Study summary

This study tests whether adding aerobic exercise to diaphragmatic breathing helps overweight and obese children with primary nocturnal enuresis (bedwetting) more than diaphragmatic breathing alone. Children aged 6 to 12 years who wet the bed at least 3 times a week are randomly assigned to one of three groups: aerobic exercise plus diaphragmatic breathing, diaphragmatic breathing alone, or a waiting-list control group. The program lasts 12 weeks. The main outcomes are the number of bedwetting episodes per week and sleep quality. Body mass index and quality of life are also compared.

Read the detailed description

Nocturnal enuresis is involuntary nighttime wetting in children aged 5 years or older. It can lower self-esteem, disturb sleep and place strain on the family. Overweight and obese children have higher rates of nocturnal enuresis and more severe symptoms, and behavioral treatment works less well for them. Raised intra-abdominal pressure, disturbed sleep and autonomic dysfunction have been proposed as reasons for this link.

Diaphragmatic breathing may reduce pelvic floor muscle tone, improve abdominal and pelvic floor coordination and balance the autonomic nervous system. Aerobic exercise may improve body composition, sleep and autonomic regulation. Their combined effect in this population has not been tested in a randomized controlled trial.

This is a three-arm, parallel-group randomized controlled trial at the pediatric physiotherapy outpatient clinic of the Faculty of Physical Therapy, Kafrelsheikh University, Egypt. Participants are recruited through advertisement in Kafr El-Sheikh governorate. Parents or guardians give written informed consent. Children are asked to stop using enuresis alarms during the study.

Group 1 receives aerobic exercise and diaphragmatic breathing. Group 2 receives diaphragmatic breathing. Group 3 is a waiting-list control group. The intervention lasts 12 weeks. Enuresis frequency is recorded by parents in an enuresis diary. Sleep quality is measured with the second part of the Child and Adolescent Sleep Checklist (CASC), given in Arabic. Quality of life is measured with the Pediatric Incontinence Questionnaire (PinQ). Body mass index is calculated from measured weight and height.

It is hypothesized that the combined intervention will give greater improvements in enuresis frequency, sleep quality, body mass index and quality of life than diaphragmatic breathing alone.

03

Conditions studied

  • Nocturnal Enuresis
  • Pediatric Obesity
  • Overweight

Keywords

  • primary nocturnal enuresis
  • aerobic exercise
  • diaphragmatic breathing
  • sleep quality
  • children
  • physical therapy
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 6 to 12 years.
  • Diagnosed with primary nocturnal enuresis.
  • 3 or more nocturnal enuresis episodes per week.
  • Overweight, defined as above the 85th percentile for age and sex.
  • Both males and females.
  • Able to follow instructions and take part in exercise sessions.

Exclusion criteria

Exclusion Criteria:

  • Neurological disorders affecting bladder control.
  • Congenital urinary tract abnormalities.
  • Diabetes mellitus.
  • Intellectual disability preventing cooperation.
  • Current use of medications affecting bladder function.
  • Secondary nocturnal enuresis caused by infection or trauma.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Aerobic Exercise Plus Diaphragmatic Breathing

    Children receive the aerobic exercise program and diaphragmatic breathing exercises for 12 weeks.

    Behavioral: Aerobic Exercise · Behavioral: Diaphragmatic Breathing

  • Active comparator
    Diaphragmatic Breathing

    Children receive diaphragmatic breathing exercises alone for 12 weeks.

    Behavioral: Diaphragmatic Breathing

  • No intervention
    Waiting List Control

    Children keep their normal daily routine. They are asked to stop enuresis alarms during the assessment period and not to drink water or other liquids for two hours before sleep.

Interventions

  • BehavioralAerobic Exercise

    Treadmill walking, running, cycling, and jumping and rhythmic activities at moderate intensity (60 to 70% of maximum heart rate), with 5 minutes of warm-up and 5 minutes of cool-down. 3 sessions per week, 45 to 60 minutes per session, for 12 weeks.

  • BehavioralDiaphragmatic Breathing

    A therapist teaches the exercises to children and parents using demonstration games and video clips. Exercises are done lying and sitting, every morning after getting up and every night before sleep, for 12 weeks. In balloon breathing the child lies on the back with knees bent, one hand on the belly and one on the chest, breathes in through the nose so the belly rises, and breathes out slowly through the mouth.

    Also known as: Balloon breathing

06

What researchers measure

Primary outcomes

  1. Frequency of nocturnal enuresis episodes per week

    Number of nocturnal enuresis episodes per week, recorded by parents in an enuresis diary. Fewer episodes is a better outcome.

    Time frame: Baseline and 12 weeks

  2. Sleep quality measured with the Child and Adolescent Sleep Checklist (CASC) total score

    Second part of the CASC, given in Arabic: 24 items scored 0 to 3 across four domains (bedtime issues, sleep breathing and unsteady sleep, parasomnia and sleep movement, daytime issues). Total score range 0 to 72. A higher score means worse sleep, and a score above 18 suggests a sleep problem.

    Time frame: Baseline and 12 weeks

Secondary outcomes

  1. Body mass index (BMI)

    Weight in kilograms divided by height in meters squared (kg/m\^2).

    Time frame: Baseline and 12 weeks

  2. Quality of life measured with the Pediatric Incontinence Questionnaire (PinQ) total score

    20 items scored 0 to 4 across five subscales. Total score range 0 to 80. A higher score means lower quality of life.

    Time frame: Baseline and 12 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Jan 2027, 2 months after the start.

Of 41 interventional studies with no phase under Nocturnal Enuresis, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 49. This study's planned 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 12, 2026
StartActual
Nov 10, 2026
Primary completionEst.
Jan 25, 2027
CompletionEst.
Jan 25, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07930351
Lead sponsor
Hungarian University of Sports Science
Responsible party
Mohamed Abdelaziz Emam (Lecturer Assistant, Basic Sciences Department, Faculty of Physical Therapy, Kafrelsheikh University; PhD Researcher, Hungarian University of Sports Science, Hungarian University of Sports Science) — Principal investigator
First posted
Nov 12, 2026
Start date
Nov 10, 2026
Primary completion
Jan 25, 2027 (estimated)
Completion
Jan 25, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Mohamed Abdelaziz Emam
principal investigator · Kafrelsheikh University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion